Clinical assessment of patient with exessive daytime sleepiness (EDS)
Abstract
Excessive daytime sleepiness (EDS) is the primary concern for many patients presenting with sleep disorder and a significant public health problem. The International Classification of Sleep Disorders (ICSD-2) includes EDS as an essential feature for three diagnostic categories: narcolepsy, hypersomnia and behaviourally induced insufficient sleep syndrome. Most frequently, insufficient sleep duration is responsible for this symptom. This review will give an overview of some of the most common causes of EDS encountered in clinical practice and identify important risk factors for excessive sleepiness. Daytime sleepiness is common but often unrecognized. As with most medical conditions, diagnosis of EDS begins with a precise history. The patient may present complaints of `tiredness' or `fatigue' rather than more specific symptoms of `sleepiness' or `drowsiness'. Therefore in this literature research paper we have summarized the various tools that have been developed along the years to assess sleepiness more objectively and with their help to explore the different aspects and causes of the excessive sleepiness. Always having in consideration that investigators must recognize the limitations of the available methods and select them according to the clinical problem being addressed. The purpose of this research paper, just like any kind of scientific writing, is to get the researchers, psychology students, readers, etc., up to date about the clinical assessment of patient with…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.